We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $4.08B
1-Year Est. Return 58.77%
This Fund
S&P 500
This Quarter Est. Return
+9.34%
1 Year Est. Return
+58.77%
3 Year Est. Return
+143.94%
5 Year Est. Return
+167.17%
10 Year Est. Return
+536.06%
AUM
$9.03B
AUM Growth
+$6.6B
Cap. Flow
+$1.53B
Cap. Flow %
16.94%
Top 10 Hldgs %
64.29%
Holding
5,395
New
546
Increased
3,017
Reduced
1,240
Closed
466

Top Buys

Rank Stock Value
1
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$487M
2
IWM icon
iShares Russell 2000 ETF
IWM
+$48.2M
3
EEM icon
iShares MSCI Emerging Markets ETF
EEM
+$29.4M
4
EFA icon
iShares MSCI EAFE ETF
EFA
+$28.9M
5
MSFT icon
Microsoft
MSFT
+$27.7M

Top Sells

Rank Stock Value
1
VXX icon
iPath Series B S&P 500 VIX Short-Term Futures ETN
VXX
+$51.8M
2
VOO icon
Vanguard S&P 500 ETF
VOO
+$38.5M
3
SOXL icon
Direxion Daily Semiconductor Bull 3X ETF
SOXL
+$32.6M
4
IVV icon
iShares Core S&P 500 ETF
IVV
+$21M
5
VTI icon
Vanguard Morningstar Total Stock Market ETF
VTI
+$16.6M

Sector Composition

Rank Sector Weight
1 Technology 6.25%
2 Industrials 4.6%
3 Consumer Discretionary 4.31%
4 Healthcare 4.26%
5 Financials 3.82%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
RFP
3951
DELISTED
Resolute Forest Products Inc.
RFP
$15K ﹤0.01%
3,336
-38,664
-92% -$145K
SSPKU
3952
DELISTED
Silver Spike Acquisition Corp. Units
SSPKU
$15K ﹤0.01%
1,418
– –
ONCS
3953
DELISTED
OncoSec Medical Incorporated
ONCS
$15K ﹤0.01%
+202
New +$15.7K
ABUS icon
3954
Arbutus Biopharma
ABUS
$906M
$14K ﹤0.01%
4,403
-6,941
-61% -$21.1K
ATNM icon
3955
Actinium Pharmaceuticals
ATNM
$30.2M
$14K ﹤0.01%
1,481
+321
+28% +$3.54K
BKSY icon
3956
BlackSky Technology
BKSY
$1.27B
$14K ﹤0.01%
170
-169
-50% -$13.7K
BTCT icon
3957
BTC Digital
BTCT
$7.99M
$14K ﹤0.01%
+4
New +$23.6K
BYND icon
3958
Beyond Meat
BYND
$210M
$14K ﹤0.01%
82
-74
-47% -$10K
CLMB icon
3959
Climb Global Solutions
CLMB
$532M
$14K ﹤0.01%
+2,432
New +$14.5K
DVOL icon
3960
First Trust Dorsey Wright Momentum & Low Volatility ETF
DVOL
$74M
$14K ﹤0.01%
+611
New +$13.5K
EWS icon
3961
iShares MSCI Singapore ETF
EWS
$1.16B
$14K ﹤0.01%
764
-616
-45% -$11.7K
GGB icon
3962
Gerdau
GGB
$9.42B
$14K ﹤0.01%
4,688
-9,942
-68% -$27.2K
HEPA
3963
DELISTED
Hepion Pharmaceuticals
HEPA
$14K ﹤0.01%
+5
New +$17.9K
KRYS icon
3964
Krystal Biotech
KRYS
$9.72B
$14K ﹤0.01%
323
-3,349
-91% -$145K
LCTX icon
3965
Lineage Cell Therapeutics
LCTX
$268M
$14K ﹤0.01%
15,325
-25,924
-63% -$22.9K
NET icon
3966
Cloudflare
NET
$118B
$14K ﹤0.01%
344
+229
+199% +$8.77K
NGL icon
3967
NGL Energy Partners
NGL
$2.13B
$14K ﹤0.01%
3,581
+2,446
+216% +$10K
PERI icon
3968
Perion Network
PERI
$384M
$14K ﹤0.01%
1,977
+1,572
+388% +$9.39K
QLC icon
3969
FlexShares US Quality Large Cap Index Fund
QLC
$1.05B
$14K ﹤0.01%
377
– –
RGLS
3970
DELISTED
Regulus Therapeutics
RGLS
$14K ﹤0.01%
2,671
-1,748
-40% -$11.5K
SAP icon
3971
SAP
SAP
$242B
$14K ﹤0.01%
95
+67
+239% +$10.6K
SEB icon
3972
Seaboard Corp
SEB
$4.08B
$14K ﹤0.01%
5
– –
TBT icon
3973
ProShares Trust UltraShort Lehman 20+ Year Treasury
TBT
$306M
$14K ﹤0.01%
868
-8,423
-91% -$129K
VIRT icon
3974
Virtu Financial
VIRT
$5.05B
$14K ﹤0.01%
605
-468
-44% -$11.7K
WMG icon
3975
Warner Music
WMG
$13.3B
$14K ﹤0.01%
500
-13,874
-97% -$405K
157 158
159
160 161

Similar funds

CA
CSM Advisors Warrendale, Pennsylvania $4.07B AUM 29.62% 1-Year Est. Return
ICP
Ilex Capital Partners London, United Kingdom $4.06B AUM 6.11% 1-Year Est. Return
AP
Altarock Partners West Palm Beach, Florida $4.13B AUM 0.04% 1-Year Est. Return
BWA
Brave Warrior Advisors New York $4.04B AUM 1.15% 1-Year Est. Return
JSW
Journey Strategic Wealth Summit, New Jersey $4.03B AUM 33.12% 1-Year Est. Return
SP
Stockbridge Partners Boston, Massachusetts $4.14B AUM 16.9% 1-Year Est. Return
GCM
Graham Capital Management Rowayton, Connecticut $4.14B AUM 17.82% 1-Year Est. Return
ZP
Zimmer Partners New York $4.15B AUM 14.2% 1-Year Est. Return

Tower Research Capital (TRC)'s Q3 2020 Portfolio in Review

As of Q3 2020, Tower Research Capital (TRC) held 5,395 positions worth $9.03B, up 271% from $2.44B the previous quarter. Its ten largest holdings account for 64% of the portfolio.

Tower Research Capital (TRC) deployed $1.53B of net new capital in Q3 2020, opening 546 new positions and adding to 3,017 existing holdings. Its largest new stake was iShares Biotechnology ETF: 34,723 shares worth $4.7M.

By sector, the portfolio is most concentrated in Technology at 6.3% of assets, down from 12% a quarter earlier, followed by Industrials and Consumer Discretionary.

On the sell side, the largest reduction was Vanguard S&P 500 ETF, an estimated $38.5M trimmed.

  • Tower Research Capital (TRC)'s largest Q3 2020 buy was iShares Biotechnology ETF: 34,723 shares worth $4.7M.
  • Tower Research Capital (TRC) added most to State Street SPDR S&P 500 ETF Trust in Q3 2020, an estimated $487M increase.
  • Tower Research Capital (TRC)'s biggest Q3 2020 reduction was Vanguard S&P 500 ETF, cutting an estimated $38.5M.
  • Tower Research Capital (TRC) fully exited iPath Series B S&P 500 VIX Short-Term Futures ETN in Q3 2020, selling an estimated $51.8M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 64% of its $9.03B portfolio in Q3 2020.
  • Tower Research Capital (TRC) opened 546 new positions and closed 466 in Q3 2020.
  • Tower Research Capital (TRC)'s portfolio value rose 271% quarter-over-quarter to $9.03B.

Based on Tower Research Capital (TRC)'s 13F filing for Q3 2020, filed 16 Nov 2020.